Richard William Scalzo
CIK 1789545 · Chief Financial Officer · last filed 2026-09-18
Richard William Scalzo is a Chief Financial Officer who has filed 65 SEC Form 4 insider transactions across 2 companies since 2020. The most recent filing shows the insider sold $10.2K of GLYC on Sep 18, 2026. Across all open-market trades the lifetime net is −$8.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.0M across reported positions. 27 Form 144 notices of planned sales are also on file; the latest, for DYN on Jun 11, 2025, lists the filer as an officer. 2 sales listed on those notices, worth $41.5K in all, have no matching Form 4.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
DYN price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
HOLLISTON, MA 01746
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CRESCENT BIOPHARMA, INC. (GLYC) Delisted | Chief Financial Officer | 19,730 | $15.70 | $309.8K | -$30.2K | 3 | 2026-09-18 |
| DYN | SVP, Head of Finance & Admin. | 122,330 | $16.04 | $1.96M | -$8.71M | 35 | 2025-03-13 |
Recent Filings
65 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-09-18 | CRESCENT BIOPHARMA, INC. (GLYC) Delisted | Sell (S)10b5-1 Plan adopted Feb 25, 2026 |
−568 | -$10.2K | EDGAR |
| 2026-06-23 | CRESCENT BIOPHARMA, INC. (GLYC) Delisted | Sell (S)10b5-1 Plan adopted Feb 25, 2026 |
−1,112 | -$20.0K | EDGAR |
| 2025-12-17 | CRESCENT BIOPHARMA, INC. (GLYC) Delisted | Grant (A) | +19,422 | $0 | EDGAR |
| 2025-06-11 | DYN | Notice (144) Officer · Planned Jun 11, 2025 No sale on file |
−1,330 | -$19.6K | EDGAR |
| 2025-06-05 | DYN | Notice (144) Officer · Planned Jun 5, 2025 Sold: listed on the Jun 11, 2025 notice |
−914 | -$12.2K | EDGAR |
| 2025-05-16 | DYN | Notice (144) Officer · Planned May 16, 2025 Sold: listed on the Jun 5, 2025 notice |
−2,479 | -$29.3K | EDGAR |
| 2025-03-13 | DYN | Sell (S)10b5-1 | −1,343 | -$15.3K | EDGAR |
| 2025-03-11 | DYN | Notice (144) Officer · Planned Mar 11, 2025 Sold: Form 4 filed Mar 13, 2025 |
−1,343 | -$15.3K | EDGAR |
| 2025-03-07 | DYN | Sell (S)10b5-1 Plan adopted Dec 4, 2024 |
−917 | -$10.8K | EDGAR |
| 2025-03-05 | DYN | Notice (144) Officer · Planned Mar 5, 2025 Sold: Form 4 filed Mar 7, 2025 |
−915 | -$10.9K | EDGAR |
10b5-1: the filer ticked the box for trades made under a Rule 10b5-1 trading plan, which sets the sales (or buys) in advance, so they say less about the insider's view at the time than a discretionary trade. The plan's adoption date is shown when the filing's footnotes give it.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment, and an amended or cancelled notice is not listed. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes. Someone who is no longer an officer or director (or never was) files no Form 4, so for them a sale shows up only on a later notice, which lists the seller's sales from the 3 months before it. "No sale on file" means neither record shows one; a dash in Net $ means the value filed on the notice doesn't fit the stock's price (likely a typo).
Sales Reported Only on Form 144
2 sales · $41.5K| Sold | Symbol | Shares | Proceeds | Avg Price | Listed On |
|---|---|---|---|---|---|
| 2025-06-05 | DYN Seller: Rick Scalzo |
914 | $12.2K | $13.35 | 2025-06-11 |
| 2025-05-16 | DYN | 2,479 | $29.3K | $11.82 | 2025-06-05 |